Elicera Therapeutics AB (publ) (STO:ELIC)
2.465
+0.025 (1.02%)
Nov 20, 2026, 5:25 PM CET
Elicera Therapeutics AB Market Cap
Elicera Therapeutics AB has a market cap or net worth of 164.51 million as of November 20, 2026. It is the 37,977th most valuable company in the world and the 532nd biggest in Sweden. Its market cap has decreased by 35.56% in one year.
Market Cap
164.51M
Enterprise Value
106.38M
Revenue
7.79M
Global Rank
Country Rank
#532 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since June 11, 2021, Elicera Therapeutics AB's market cap has increased from 122.65M to 164.51M, an increase of 34.13%. That is a compound annual growth rate of 5.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 164.51M | -35.07% |
| Dec 30, 2025 | 253.36M | 332.30% |
| Dec 30, 2024 | 58.61M | -35.03% |
| Dec 29, 2023 | 90.21M | 29.73% |
| Dec 30, 2022 | 69.53M | -29.98% |
| Dec 30, 2021 | 99.31M | -19.03% |
| Jun 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Intervacc AB | 224.94M |
| Mendus AB | 217.29M |
| Xbrane Biopharma AB | 213.27M |
| Initiator Pharma | 171.13M |
| Abera Bioscience AB | 140.62M |
| Diamyd Medical AB | 138.25M |
| BioInvent International AB | 137.53M |
| Simris Group AB (PUBL) | 137.49M |